By TNT Bureau
Jan 25, 2016: Following the report published in Harvard Gazette, clinical trials on artificial pancreas for diabetics will soon take off and hence, we might get to see it as a wearable health device in the near future.
An innovative, technology-enable artificial pancreas is unlike any other replica organ. It is being said the new system will assist with automatic insulin delivery. The best part of it all is that you can even connect it to your smartphone.
With the announcement of such soon-to-born technology, diabetics around the world can finally breathe a sigh of relief. In fact, most of the people can now look forward to wearable artificial pancreas that will help them in maintaining their blood sugar levels in the most technological and effective manner possible.
Some vital information on the clinical trials
It is being said that the researchers will soon go ahead with a number of clinical experimentation in order to test the ability of artificial pancreases in regulating the levels of blood sugar among people who suffer from type 1 diabetes. This is going to be one of the huge and long-standing clinical experimentation as far as such system is concerned.
It is the University Of Virginia School Of Medicine and the Harvard John A. Paulson School of Engineering and Applied Sciences that have come up with this entirely new and innovative system. The financial aid was given by National Institutes of Health.
Talks have it that 2 clinical trials are to be conducted. The UVA and Harvard will be responsible for conducting these two clinical trials. It is being said that the clinical trials scan over 420 people who are suffering from diabetes at 9 sites across Europe as well as US for a period of 6 months.
What is the goal for developing artificial pancreas?
The director of the UVA Center for Diabetes Technology Boris Kovatchev said that the primary goal is to set up a new diabetes treatment standard: the artificial pancreas is going to be a multi functional health device. It will be a flexible wearable system adjoining the patient in a digital treatment ecosystem.
The artificial pancreas system will consist of a glucose monitor, algorithm software entrenched in a smartphone and an insulin pump, said Boris.
The clinical trials will be held at important sites such as the Mayo Clinic, the Regional University Hospital Center of Montpellier, France, the University of Stanford, the Padua University, Mount Sinai Hospital in New York etc.
With the rate of obesity speeding up in the U.S. continue to climb, it is believed the number of diabetic patients will also increase and will soon reach a mammoth total. Hence, with the development of the artificial pancreas, it is believed that some sort of relief will definitely be given to the diabetics to regulate as well as lower down their blood sugar levels.